Alkyl ketene dimer (AKD) and alkenyl succinic anhydride (ASA) are both internal sizing agents used to control liquid penetration into paper, but they behave differently and are usually claimed separately or in combination compositions. AKD is generally associated with slower cure and a higher risk of sizing reversion over time, while ASA cures faster but can show emulsion stability issues before application. Many filings in this dataset, including the representative record covered on this page, claim dosage ranges for both agents within a single composition rather than treating them as mutually exclusive chemistries. When searching prior art, treat AKD-only, ASA-only and combined-agent claims as three distinct search buckets.

Sizing reversion, where paper loses its water resistance after storage or exposure to heat and humidity, is one of the main technical failure modes that drives continued filing activity in this field. Because it directly affects the commercial usability of AKD-sized paper, formulators keep filing improvement claims around additive packages, cure conditions and metallic salt incorporation aimed at reducing reversion. The dataset's search scope specifically includes hydrolysis loss and sizing reversion as core technical terms, which is why they recur heavily across the most-cited records.

The field shows meaningful concentration at the top: the five leading assignees together hold 1,535 of the 6,899 records in scope, or 22.2% of all records. That said, the ranked list extends to 100 companies, with a steep drop from the leader's 326 records down to 149 at tenth place, indicating a small core of heavy filers surrounded by a much larger group of lighter filers. This is a concentrated-but-not-monopolised field, which typically leaves room for freedom-to-operate analysis around specific dosage ranges or additive combinations rather than the core chemistry itself.

Filing volume peaked at 206 records in 2017 and has since settled into a lower, relatively stable range, moving from 143 records in 2021 to 140 in 2024 — a -2% change over three years. That is best read as a plateau rather than a decline, since publication typically lags actual filing by around 18 months, meaning 2025 and 2026 figures are still incomplete and will revise upward. Any conclusion about the field slowing down should wait until at least the 2025 filing year is fully published.

Based on IPC composition, the heaviest claim density sits in D21H (pulp and paper compositions, 61.8% of records) and B41M (printing and marking, 24.9%), while classes tied to packaging (B65D, 4.7%) and electrophotographic media (G03G, 4.7%) carry far less. That gap suggests packaging-grade barrier sizing and electrophotographic-specific sizing formulations are comparatively under-claimed relative to the core paper-composition space. A first claim in those areas would likely need to tie the sizing agent's dosage or emulsion characteristics specifically to the packaging or imaging performance requirement rather than to general paper sizing.